AI assistant
INCYTE CORP — Director's Dealing 2023
Jul 18, 2023
30371_dirs_2023-07-18_01e1b2c0-175a-4a33-aea4-6b54f586da92.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INCYTE CORP (INCY)
CIK: 0000879169
Period of Report: 2023-07-14
Reporting Person: CAGNONI PABLO J (President, R&D)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-07-14 | Common Stock | A | 9668 | $0.00 | Acquired | 202068 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-07-14 | Employee Stock Option (right to buy) | $61.76 | A | 20275 | Acquired | 2033-07-13 | Common Stock (20275) | Direct |
Footnotes
F1: Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years, subject to Pablo Cagnoni's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
F2: Including the July 14, 2023 RSU Grant, this includes an aggregate of 202,068 shares of common stock issuable pursuant to previously reported RSUs that have not vested.
F3: The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.